AAV-Based Gene Therapies
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
6
NCT06662188
JAG201 Gene Therapy Study in Children & Adults With SHANK3 Haploinsufficiency
Phase: Phase 1/2
Role: Lead Sponsor
Start: Jan 7, 2024
Completion: Jun 30, 2031
Loading map...